Skip to content

Bioventus BVS Unrealized Gain (Loss), Foreign Currency Transaction, before Tax

Unrealized Gain (Loss), Foreign Currency Transaction, before Tax at other companies

Ceco Environmental logo
Ceco EnvironmentalCECO
-$624K-155%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$1.1M-267%
Appian Corporation logo
Appian CorporationAPPN
-$1.12M-128%
IPG Photonics logo
IPG PhotonicsIPGP
$672K+1,700%
Sotera Health logo
Sotera HealthSHC
$2.1M+139%
CarGurus, Inc. logo
CarGurus, Inc.CARG
-$129K-178%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossUnrealized.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's unrealized gain (loss), foreign currency transaction, before tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's unrealized gain (loss), foreign currency transaction, before tax?
Bioventus (BVS) reported unrealized gain (loss), foreign currency transaction, before tax of -$54K in Q1 2026.
How has Bioventus's unrealized gain (loss), foreign currency transaction, before tax changed year-over-year?
Bioventus's unrealized gain (loss), foreign currency transaction, before tax decreased by 122.3% year-over-year, from $242K to -$54K.
What is the long-term trend for Bioventus's unrealized gain (loss), foreign currency transaction, before tax?
Over 2 years (2021 to 2025), Bioventus's unrealized gain (loss), foreign currency transaction, before tax has grown at a -8.9% compound annual growth rate (CAGR), from -$472K to $392K.
What does unrealized gain (loss), foreign currency transaction, before tax mean?
Captures the impact of exchange rate fluctuations on monetary assets and liabilities denominated in foreign currencies that have not yet been settled. This metric highlights the company's exposure to currency volatility and its potential impact on operating cash flow before tax effects.